{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:03Z","timestamp":1788532023800,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Osteosarcoma (OS) is a common clinical malignant bone tumor. This study aimed to identify M2 macrophage-associated factors to construct a prognostic model for OS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The osteosarcoma-related profiles including expression data and clinical information were obtained from TCGA and NCBI Gene Expression Omnibus, respectively. The M2 macrophage-associated differentially expressed RNAs (DERs) were identified between metastasis and nonmetastasis samples. LASSO Cox regression approach was applied to select the prognostic feature M2 macrophage-associated RNAs to construct a prognostic score (PS) model. The Kaplan\u2013Meier approach was applied to analyze the survival. Univariate and multivariate Cox regression analysis were performed to screen the independent clinical prognostic factors. Receiver operating characteristic (ROC) curves were utilized to compare the effects of the prognostic models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 153 M2 macrophage-related DERs were determined. 12 M2 macrophage-associated RNAs were identified to establish the PS model. The high risk group was associated with the shorter survival. Age, tumor metastatic and PS model status were determined as the independent clinical prognostic factors. ROC curves showed that the combined model performed well on predicting the survival of OS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study provided several M2 macrophage-associated factors as the valuable prognostic biomarkers for OS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048626","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:00:52Z","timestamp":1778896852000},"page":"e48626","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["M2 macrophage-associated factors for constructing a prognostic model for osteosarcoma"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-2769","authenticated-orcid":false,"given":"Jian","family":"Han","sequence":"first","affiliation":[{"name":"First Department of Orthopedic Surgery, North Hospital, Qiqihar First Hospital, Qiqihar City, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int J Cancer"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/cancers12082130","article-title":"Molecular biology of osteosarcoma.","volume":"12","author":"Czarnecka","year":"2020","journal-title":"Cancers"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/cells10010172","article-title":"Future directions in the treatment of osteosarcoma.","volume":"10","author":"Smrke","year":"2021","journal-title":"Cells"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/14737140.2016.1168697","article-title":"Metastatic osteosarcoma: a challenging multidisciplinary treatment.","volume":"16","author":"Meazza","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/receptors3040021","article-title":"Receptor-based strategies for overcoming resistance in cancer therapy.","volume":"3","author":"Sah","year":"2024","journal-title":"Receptors"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment.","volume":"56","author":"Arneth","year":"2020","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment.","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets.","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s13402-021-00598-w","article-title":"The role of tumor-associated macrophages in osteosarcoma progression \u2013 therapeutic implications.","volume":"44","author":"Huang","year":"2021","journal-title":"Cell Oncol"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/2326-6066.CIR-16-0259","article-title":"All-trans retinoic acid prevents osteosarcoma metastasis by inhibiting M2 polarization of tumor-associated macrophages.","volume":"5","author":"Zhou","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"78343","DOI":"10.18632\/oncotarget.13055","article-title":"Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.","volume":"7","author":"Dumars","year":"2016","journal-title":"Oncotarget"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.3390\/ijms21155207","article-title":"Tumor-associated macrophages in osteosarcoma: from mechanisms to therapy.","volume":"21","author":"Cersosimo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1007\/s13277-014-2005-y","article-title":"Inhibition of macrophage polarization prohibits growth of human osteosarcoma.","volume":"35","author":"Xiao","year":"2014","journal-title":"Tumour Biol"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer.","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis.","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2018.10.011","article-title":"Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2\/STAT3 axis.","volume":"440-441","author":"Han","year":"2019","journal-title":"Cancer Lett"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.","volume":"17","author":"Buddingh","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbo.2016.03.004","article-title":"The role of tumour-associated macrophages in bone metastasis.","volume":"5","author":"Sousa","year":"2016","journal-title":"J Bone Oncol"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-019-1102-3","article-title":"Harnessing tumor-associated macrophages as aids for cancer immunotherapy.","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12885-022-09223-x","article-title":"Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases.","volume":"22","author":"Ma","year":"2022","journal-title":"BMC Cancer"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"e70183","DOI":"10.1002\/ddr.70183","article-title":"Kaurenoic acid suppresses osteosarcoma progression by reprogramming tumor-associated macrophages to M1 phenotype.","volume":"86","author":"Tang","year":"2025","journal-title":"Drug Dev Res"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s12672-025-03214-7","article-title":"Construction of an immune prediction model for osteosarcoma based on coagulation-related genes.","volume":"16","author":"Jiang","year":"2025","journal-title":"Discov Oncol"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma.","volume":"152","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat Res"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bone.2011.08.014","article-title":"Age as prognostic factor in patients with osteosarcoma.","volume":"49","author":"Hagleitner","year":"2011","journal-title":"Bone"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"780264","DOI":"10.3389\/fonc.2021.780264","article-title":"Osteosarcoma and metastasis.","volume":"11","author":"Sheng","year":"2021","journal-title":"Front Oncol"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13058-023-01615-6","article-title":"Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer.","volume":"25","author":"Chinnadurai","year":"2023","journal-title":"Breast Cancer Res"},{"issue":"1_Supplement","key":"R27-20260904","doi-asserted-by":"crossref","first-page":"C027","DOI":"10.1158\/1538-7755.DISP22-C027","article-title":"Abstract C027: miRNA-214-5P regulates RAD51, a biomarker for aggressive disease and racial disparities in triple-negative breast cancer.","volume":"32","author":"Acharya","year":"2023","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8_Supplement_1","key":"R28-20260904","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1158\/1538-7445.AM2025-3090","article-title":"Abstract 3090: miRNA-221-5p-mediated epigenetic regulation promotes chemoresistance and offers therapeutic potential in ovarian cancer.","volume":"85","author":"Omy","year":"2025","journal-title":"Cancer Res"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"16529","DOI":"10.18632\/oncotarget.7664","article-title":"Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt\/GSK-3\u03b2\/\u03b2-catenin pathway.","volume":"7","author":"Yangchun","year":"2016","journal-title":"Oncotarget"},{"key":"R30-20260904","first-page":"1011","article-title":"miR-874 inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer.","volume":"49","author":"Baofei","year":"2013","journal-title":"J Gastroenterol"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.actbio.2022.09.026","article-title":"Polymeric photothermal nanoplatform with the inhibition of aquaporin 3 for anti-metastasis therapy of breast cancer.","volume":"153","author":"Luo","year":"2022","journal-title":"Acta Biomater"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:00:45Z","timestamp":1788530445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":31,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048626","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}